Thermo Fisher Raises 2026 Outlook After $12.14 Billion in Q3 Revenue

John Kim

1 min read

Add as a preferred source on Google

Thermo Fisher Raises 2026 Outlook After $12.14 Billion in Q3 Revenue

Adjusted earnings reached $6.68 per share, with Laboratory Products and Biopharma Services leading the quarter.

By John Kim

Published Oct 21, 2026, 4:50 PM EDT

One glass sample vial rises above a row of others. / TokenPost.ai

Thermo Fisher Scientific Inc. raised its 2026 outlook after recording $12.14 billion in third-quarter revenue and $6.68 in adjusted earnings per share, with Laboratory Products and Biopharma Services leading performance.

The life sciences company generated $11.99 billion in revenue in the second quarter of 2026, up 10% from a year earlier. Adjusted earnings were $6.03 per share for that period. Both revenue and adjusted earnings per share were higher in the third quarter.

Thermo Fisher shares traded higher Wednesday morning, Oct. 21, following the results and outlook update.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.